Search

Did you mean: science insights?

Definitive Treatment in Transition: De-Escalation, Biomarkers and Immunotherapy in Head and Neck Radiation Oncology

optimization. Finally, we highlight future directions and emerging … optimization. Finally, we highlight future directions and emerging … research/grant funding from Gilead Sciences (relationship ended 8/30/2025 …
Practical Radiation Oncology Program 2025

ownership equity in Droplet Biosciences and LiquidCell Dx, Inc. … Astrazeneca, AVDL, AXSM, Interra Neuroscience, iPath and Zeto, Inc. Speakers: … research/grant funding from Gilead Sciences (relationship ended 8/30/2025 …

You are here